| 000 | 01432 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250516122907.0 | ||
| 264 | 0 | _c20130809 | |
| 008 | 201308s 0 0 eng d | ||
| 022 | _a1473-4877 | ||
| 024 | 7 |
_a10.1185/03007995.2012.753430 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHochberg, M | |
| 245 | 0 | 0 |
_aSymptom and structure modification in osteoarthritis with pharmaceutical-grade chondroitin sulfate: what's the evidence? _h[electronic resource] |
| 260 |
_bCurrent medical research and opinion _cMar 2013 |
||
| 300 |
_a259-67 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aBone and Bones _xdrug effects |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aChondrocytes _xdrug effects |
| 650 | 0 | 4 |
_aChondroitin Sulfates _xadverse effects |
| 650 | 0 | 4 |
_aCollagen Type II _xmetabolism |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInflammation Mediators _xmetabolism |
| 650 | 0 | 4 |
_aOsteoarthritis _xdiagnosis |
| 650 | 0 | 4 |
_aProteoglycans _xmetabolism |
| 650 | 0 | 4 |
_aSynovial Membrane _xdrug effects |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aChevalier, X | |
| 700 | 1 | _aHenrotin, Y | |
| 700 | 1 | _aHunter, D J | |
| 700 | 1 | _aUebelhart, D | |
| 773 | 0 |
_tCurrent medical research and opinion _gvol. 29 _gno. 3 _gp. 259-67 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1185/03007995.2012.753430 _zAvailable from publisher's website |
| 999 |
_c22296015 _d22296015 |
||